Tags

Type your tag names separated by a space and hit enter

Prediction of response to ergocryptine in the galactorrhea-amenorrhea syndrome.
Fertil Steril. 1978 Oct; 30(4):388-92.FS

Abstract

Forty women with secondary amenorrhea and galactorrhea, thirty-six of whom had associated hyperprolactinemia, were studied prior to therapy with ergocryptine. Abnormal sella tomographic findings were present in 23. The findings on sellar tomography, basal serum prolactin concentrations, and pharmacologic stimulation/suppression of the serum prolactin failed to predict subsequent responders and nonresponders to ergocryptine. Pituitary stimulation for hormone responsiveness did differentiate subsequent responders to ergocryptine from nonresponders. The serum growth hormone response to hypoglycemia was the most definitive predictor. Return of apparently ovulatory function occurred in 29 patients, 11 of whom conceived and have delivered healthy infants.

Authors

No affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

581377

Citation

Corenblum, B, and P J. Taylor. "Prediction of Response to Ergocryptine in the Galactorrhea-amenorrhea Syndrome." Fertility and Sterility, vol. 30, no. 4, 1978, pp. 388-92.
Corenblum B, Taylor PJ. Prediction of response to ergocryptine in the galactorrhea-amenorrhea syndrome. Fertil Steril. 1978;30(4):388-92.
Corenblum, B., & Taylor, P. J. (1978). Prediction of response to ergocryptine in the galactorrhea-amenorrhea syndrome. Fertility and Sterility, 30(4), 388-92.
Corenblum B, Taylor PJ. Prediction of Response to Ergocryptine in the Galactorrhea-amenorrhea Syndrome. Fertil Steril. 1978;30(4):388-92. PubMed PMID: 581377.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Prediction of response to ergocryptine in the galactorrhea-amenorrhea syndrome. AU - Corenblum,B, AU - Taylor,P J, PY - 1978/10/1/pubmed PY - 1978/10/1/medline PY - 1978/10/1/entrez SP - 388 EP - 92 JF - Fertility and sterility JO - Fertil Steril VL - 30 IS - 4 N2 - Forty women with secondary amenorrhea and galactorrhea, thirty-six of whom had associated hyperprolactinemia, were studied prior to therapy with ergocryptine. Abnormal sella tomographic findings were present in 23. The findings on sellar tomography, basal serum prolactin concentrations, and pharmacologic stimulation/suppression of the serum prolactin failed to predict subsequent responders and nonresponders to ergocryptine. Pituitary stimulation for hormone responsiveness did differentiate subsequent responders to ergocryptine from nonresponders. The serum growth hormone response to hypoglycemia was the most definitive predictor. Return of apparently ovulatory function occurred in 29 patients, 11 of whom conceived and have delivered healthy infants. SN - 0015-0282 UR - https://www.unboundmedicine.com/medline/citation/581377/Prediction_of_response_to_ergocryptine_in_the_galactorrhea_amenorrhea_syndrome_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0015-0282(16)43569-7 DB - PRIME DP - Unbound Medicine ER -